Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 51.00K | 39.00K | 75.00K | 42.00K | 78.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.00K | 39.00K | 75.00K | 42.00K | 78.00K |
| Cost of Revenue | 278.00K | 313.00K | 21.00K | 203.00K | 234.00K |
| Gross Profit | -227.00K | -274.00K | 54.00K | -161.00K | -156.00K |
| SG&A Expenses | 2.21M | 2.04M | 1.70M | 2.85M | 2.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.62M | 6.00M | 6.27M | 5.75M | 5.15M |
| Operating Income | -5.57M | -5.96M | -6.20M | -5.71M | -5.07M |
| Income Before Tax | -5.98M | -4.35M | -6.59M | -6.48M | -5.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.98M | -4.35M | -6.59M | -6.48M | -5.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.98M | -4.35M | -6.59M | -6.48M | -5.69M |
| EBIT | -5.57M | -5.96M | -6.20M | -5.71M | -5.07M |
| EBITDA | -5.50M | -5.89M | -6.12M | -5.63M | -4.99M |
| EPS Basic | -0.07 | -0.08 | -0.27 | -0.35 | -0.32 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.14 | -0.19 | -0.17 |
| EPS Diluted | -0.07 | -0.08 | -0.27 | -0.35 | -0.32 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.14 | -0.19 | -0.17 |
| Average Basic Shares Outstanding | 104.04M | 68.94M | 28.47M | 21.85M | 21.38M |
| Average Diluted Shares Outstanding | 104.04M | 68.94M | 28.47M | 21.85M | 21.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.00% | -10.67% |